Dr. Susan Srivatsa is the Founder and President of ElixinPharma, a pharmaceutical regulatory consulting firm that provides scientific and technical leadership in the area of Chemistry, Manufacturing and Controls (CMC) for a number of leading companies in various stages of clinical development. The firm specializes in supporting the development of novel technologies such as DNA...